The Monitoring Program includes substances which are not on the Prohibited List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport. A spokesperson for Novo Nordisk said in a statement that the pharmaceutical company, which produces and distributes GLP-1s, agreed with WADAs decision to monitor GLP-1 usage: We are supportive of the WADA recommendation, and we strongly discourage use/promotion outside the indicated population and approved label. Advertisement A spokesperson for Eli Lilly, another company that manufactures and distributes GLP-1s, said: Zepbound (tirzepatide) and Foundayo (orforglipron) are indicated for use, along with diet and exercise, for adults with obesity or overweight and a weight-related comorbidity
Dont confuse the two
Targeted phage cocktail therapy achieves a reduction in pathogenic bacterial load while preserving commensal microbiota stability (Nishijima et al., 2022
In May, Judge Pittman dismissed a similar challenge involving Eli Lillys Zepbound and Mounjaro, a case that is now under appeal
The process will take about 2-4 hours, and can be done on an outpatient basis
